ギャンボラカジノ入金不要ボーナス

Corporate Corporate Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center  Digital Showroom  Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Products Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investors Investors Management Policy Message from the President --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data ∟Financial Highlight ∟Historical DATA  Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information ∟Stock Information ∟Dividend ∟Shareholders Meeting ∟Articles of Incorporation ∟Ratings and Bonds Sustainability Sustainability Sustainability Activities Sustainability Approach and Promotion Structure Material Issues and　Sustainability(MOS) Indices​ ESG Initiatives Environment Social Governance Sustainability Data Sustainability (MOS) Results Non-Financial Data Sheets GRI Standards Integrated report "KAITEKI Report" News News Releases Information IR News TSE Filings Contact Us 日本語 English 中文 --> --> --> --> HOME Corporate Information Corporate Profile / Access Corporate Profile / Access As of May 15, 2024 Mitsubishi Chemical Group Corporation Mitsubishi Chemical Corporation Mitsubishi Tanabe Pharma Corporation Nippon Sanso Holdings Corporation Mitsubishi Chemical Group Corporation Company name Mitsubishi Chemical Group Corporation Head office 1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8251 View on Google Maps Access ・8-minutes walk from the Marunouchi North Exit of JR Tokyo Station・One-minute walk from Exit C13b of Otemachi Station (subway) Representative Representative Corporate Executive Officer, President & Chief Executive Officer, Manabu Chikumoto Date of establishment October 3, 2005 Paid-in capital 50 billion yen Main scope of business Management of Group companies(Development of the Group strategies and allocation of financial resource) Sales revenue (Consolidated) 4,387.2 billion yen (FY2023) Number of employees 66,358 (Consolidated), 501 (Non-consolidated) 　(As of March 31, 2024) Subsidiaries and affiliates 552 (Consolidated subsidiaries:390 As of March 31, 2024) Listings The Prime Market of Tokyo Stock Exchange Fiscal year end March 31 Mitsubishi Chemical Corporation Company name Mitsubishi Chemical Corporation Head office 1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8251 View on Google Maps Access ・8-minutes walk from the Marunouchi North Exit of JR Tokyo Station・One-minute walk from Exit C13b of Otemachi Station (subway) Representative Representative Director, Yasuo ShimodairaRepresentative Director, Manabu Chikumoto Date of incorporation April 1, 2017 (Date of foundation: August 31, 1933) Paid-in capital 53,229 million yen Line of business Performance products, industrial materials, and others Number of employees 40,736 (Consolidated), 13,462 (Non-consolidated) 　(As of March 31, 2024) Shareholder Mitsubishi Chemical Group Corporation 100% Mitsubishi Chemical Corporation : Related Information Mitsubishi Tanabe Pharma Corporation Company name Mitsubishi Tanabe Pharma Corporation Head office 2-10 Dosho-machi, 3-chome, Chuo-ku, Osaka 541-8505 View on Google Maps Access ・8-minutes walk from Exit 11 of Yodoyabashi Station on the Subway Midosuji Line.・10-minutes walk from Exit 6 of Kitahama Station on Subway Sakaisuji Line. Representative Representative Director, Akihiro TsujimuraRepresentative Director, Hiroaki Ueno Date of incorporation October 1, 2007 Paid-in capital 50 billion yen Line of business Manufacture and sale of pharmaceuticals, centered on ethical drugs Number of employees 5,577 (Consolidated) , 3,044 (Non-consolidated）（As of March 31, 2024） Shareholder Mitsubishi Chemical Group Corporation 100% Website of Mitsubishi Tanabe Pharma Corporation Nippon Sanso Holdings Corporation Company name Nippon Sanso Holdings Corporation Head office Toyo Bldg., 1-3-26 Koyama, Shinagawa-ku Tokyo 142-8558, Japan View on Google Maps Access ・Transit to the Tokyu Meguro Line at the JR Meguro Station and get off at the Fudomae Station.7 minutes’ walk from the Fudomae Station to our head office. Representative Representative Director, President CEO　Toshihiko Hamada Date of incorporation July 19, 1918(Date of establishment: October 30, 1910) Paid-in capital 37,344 million yen Line of business Subsidiary management and group operations in industrial gas Number of employees Consolidated：19,533 (As of March 31, 2024) Shareholder Mitsubishi Chemical Group Corporation 50.6％ Website of Nippon Sanso Holdings Corporation Corporate Information Corporate Information Corporate Information Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center Digital Showroom Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Business・Products Business・Products Innovation Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investor Relations Investor Relations Investor Relations Management Policy Message from the President --> Message from the CFO --> Outside Directors’ Discussion Meeting --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information Sustainability Sustainability Sustainability Sustainability Activities Sustainability approach and promotion structure Material Issues and Sustainability(MOS) Indices ESG Initiatives Environment Society Governance Sustainability Data Sustainability (MOS) results Non-Financial Data Sheets GRI Standards KAITEKI Solution Center News Releases Information Digital Showroom Contact Us FAQ The Mitsubishi Chemical Group Official Accounts Sitemap Terms of Use Privacy Policy Social Media Terms of Use Copyright © Mitsubishi Chemical Group Corporation.